Retrolaminar Block Versus Tab Block in Abdomioasty

Comparison Between US Guided Retrolaminar Block and Transversus Abdominis Plane Block for Post Operative Analgesia in Patient Undergoing Abdominal Plastic Surgery

The aim of the study is to compare the analgesic efficacy of Us guided retrolaminar block versus transversus abdominis plane block in patient under going abdominal plastic surgery

Study Overview

• Status: Recruiting
• Conditions: Block
• Intervention / Treatment: Procedure: Tab block versus retrolaminar block in abdominal plastic surgery

Detailed Description

Pain from intra abdominal surgery is a combination of somatic and visceral pain visceral pain transmitted by autonomic nervous system via sympathetic fibers from plexuses in close proximity to the viscera them selves Regional anesthetic are commonly used to prevent or minimize these side effect the use of ultra sound nerve block are commonly use as apart of multimodal post operative analgesia The tab block is used to decrease the need of post operative analgesia in patient undergoing abdominal plastic surgery It was found an alternative approach to para vertebral block the retro laminar block is performed with us guided imaging to reduce pain post operative and need analgesia

• Study Type: Interventional
• Enrollment (Estimated): 90
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Hadeel Elsagheer, Master; Phone Number: 01090884208; Email: Dodoelsagheer@gmail.com
• Study Contact Backup: Name: Tayseer Abdelrahman

Study Locations

• Egypt
  • Tanta, Egypt
    • Recruiting
    • TantaU U
    • Contact: Hadeel Elsagheer, Master

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

- 90patients aged 18/65years of both sexes and asa physical status one two and three undergoing abdominal plastic surgery

Exclusion Criteria:

• patient refusal Patient taking analgesia of chronic illness or have history of substance abuse Patient who are unable to describe their post operative pain Patient with history of coagulabathy Un cooperative patient Patient with known allergy to study drug Patient with infection at site needle puncture Patient with decompensated hepatic renal respiratory or cardiac disorder

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Prevention
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Retrolaminar block in abdominal plastic surgery; In first group induction done with general anaesthia then Patient will receive bilateral us guided rertrolaminar block then bubivacane ,25%with dexa methasone 4mg as addiditive injected on the lamina at dose 20ml injected each side	Procedure: Tab block versus retrolaminar block in abdominal plastic surgery; i inject 20ml bupivacine either 4mg dead in each side
Active Comparator: Tab block as post operative analgesia in abdominal plastic surgery; In secound group after general anaesthia induction bilateral us guided tap block with ,25%bupivacaine with dexamethasone 4mg as addiditve injected on the lamina at doses 20ml in each side	Procedure: Tab block versus retrolaminar block in abdominal plastic surgery; i inject 20ml bupivacine either 4mg dead in each side

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Total dose of morphine consumption in the first postoperative 24hours	Total dose of morphine consumption in the first postoperative 24hours	First 24hours

Collaborators and Investigators

• Sponsor: Tanta University
• Investigators: Principal Investigator: Hadeel Elsagheer, Tanta University

Study record dates

Study Major Dates

• Study Start (Actual): January 15, 2024
• Primary Completion (Estimated): October 15, 2025
• Study Completion (Estimated): December 15, 2025

Study Registration Dates

• First Submitted: February 11, 2024
• First Submitted That Met QC Criteria: February 11, 2024
• First Posted (Actual): February 20, 2024

Study Record Updates

• Last Update Posted (Actual): February 20, 2024
• Last Update Submitted That Met QC Criteria: February 11, 2024
• Last Verified: February 1, 2024

More Information

Terms related to this study

• Other Study ID Numbers: 36264

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No